ILCA 2024 Annual Conference

Now available: on-demand recordings!
We appreciate your interest in our content and hope it will provide you with valuable information and insights.

Session Details:

Day 1

• Session 1: Opening Ceremony
• Session 2: Bench to Bedside: Emerging Therapeutic Targets for Liver Cancer 
• Session 3: Clinical state of the art 
• Session 4: General Session 1 - Molecular Pathogenesis, Cell Biology and Translational Research and Poster blast 
• Session 5: Management of unresectable liver localized 
• Session 6: Bayer Industry Symposium

Day 2

• Session 1: Breakfast EISAI Symposium
• Session 2: Translational spotlight on CCA 
• Session 3: ILCA Advocacy
• Session 4: Presidential Address and Awards Ceremony 
• Session 5: General Session 2: Epidemiology, Staging and Prognosis 
• Session 6: Roche Industry Symposium
• Session 7: ILCA Debates
• Session 8: General Session 3 - Surveillance and diagnosis
• Session 9: Tumor Board
• Session 10: AstraZeneca Industry Symposium
• Session 11: Y-ILCA Masterclass

Day 3

• Session 1: Grant Session - TACE Combined with ICI in uHCC: cross-overview
• Session 2: Clinical symposium: Comprehensive management of the patient: Beyond HCC-directed therapy 
• Session 3: Basic State of the Art
• Session 4: General Session 4: Therapy & Miscellaneous 
• Session 5: Surgical resection: East meets West 
• Session 6: ILCA, AASLD and CASL  joint symposium : Prevention and surveillance
• Session 7: Deep Dive on Clinical Trials 
• Session 8: Treatment response biomarkers